AstraZeneca boosts patent portfolio with lung drug acquisition

30-07-2014

AstraZeneca boosts patent portfolio with lung drug acquisition

bochimsang12 / Shutterstock.com

UK-based pharmaceutical company AstraZeneca has boosted its patent portfolio with the acquisition of rights to Spanish company Almirall’s lung drugs, including Eklira (aclidinium).


AstraZeneca; Almirall; Eklira; mergers and acquisitions

LSIPR